A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
Clinical trial NCT03920852 · COMPLETED
Trial details
- NCT number
- NCT03920852
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2019-12-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.